Hepatitis Market Research Reports & Industry Analysis

Global Alcoholic Hepatitis Market: Industry Overview The global alcoholic hepatitis market is primarily driven by the increasing prevalence of global alcohol consumption, rising alcohol-related liver diseases, and increased public awareness of liver health. Alcoholic hepatitis, a severe form of alco ...

Global Hepatitis D Market, Analysis and Forecast: 2025-2035 Hepatitis D is a rare, serious, liver disease caused by the hepatitis D virus (HDV), which can only infect individuals who are already infected with the hepatitis B virus (HBV). The virus causes significant liver damage, leading to symptoms ...

According to our (Global Info Research) latest study, the global Hepatitis B Vaccines market size was valued at US$ 1404 million in 2024 and is forecast to a readjusted size of USD 2143 million by 2031 with a CAGR of 6.3% during review period. Hepatitis B vaccine is a vaccine that prevents hepatitis ...

Report Scope This report offers an analysis of the global market for infectious disease therapeutics, vaccines, and diagnostics. The infectious diseases covered in the report include human immunodeficiency virus (HIV) infection, seasonal influenza (including influenza A and B), hepatitis B, hepatiti ...

Global Hepatitis B Treatment Market to Reach US$5.4 Billion by 2030 The global market for Hepatitis B Treatment estimated at US$4.7 Billion in the year 2024, is expected to reach US$5.4 Billion by 2030, growing at a CAGR of 2.3% over the analysis period 2024-2030. Acute Type, one of the segments ana ...

Global Hepatitis B and C Diagnostics Market to Reach US$9.6 Billion by 2030 The global market for Hepatitis B and C Diagnostics estimated at US$6.8 Billion in the year 2024, is expected to reach US$9.6 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Immunodiagnostics, ...

Global antiviral drugs market is estimated to be valued at USD 67.04 Bn in 2025 and is expected to exhibit a CAGR of 5.3% during the forecast period (2025-2032). The global antiviral drugs market has been witnessing steady growth over the past few years. Antiviral drugs, also known as antiviral agen ...

This study covers the world outlook for viral hepatitis and retrovirus diagnostic tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent s ...

This study covers the world outlook for mono hepatitis B vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of ...

This study covers the world outlook for viral infection treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is o ...

This study covers the world outlook for hepatitis b therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of ...

This study covers the world outlook for hepatitis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of th ...

This study covers the world outlook for hepatitis c therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of ...

This study covers the world outlook for hepatitis test solution-diagnosis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the count ...

This study covers the world outlook for hepatitis c therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the ...

This study covers the world outlook for anti-hepatitis drugs and vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the count ...

This study covers the world outlook for hepatitis b diagnostic tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is ...

This study covers the world outlook for hepatitis c treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of th ...

This study covers the world outlook for hepatitis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the regio ...

This study covers the world outlook for hepatitis b vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the ...

This study covers the world outlook for hepatitis c drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the reg ...

This study covers the world outlook for hepatitis diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the ...

The human liver model is a scientific and technological representation of the human liver that is used to study its structure, function, and behavior in various physiological and pathological conditions. These models are crucial for applications in drug discovery, toxicology testing, disease modelin ...

The 2025 Global Forecast for Hepatitis E Diagnostic Tests Market (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market for over 50 countries. The product or service category is within the NAICS Medical L ...

The 2025 Global Forecast for Hepatitis C Virus Envelope Protein E2 Market (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market for over 50 countries. The product or service category is within the NAICS ...